Martin Fassnacht.

Results Patients From June 2004 through October 2009, a complete of 304 sufferers were signed up for the study. On December 10 The database was shut for final analysis, 2010. Demographic characteristics of the sufferers and baseline clinical features thatContinue reading… Martin Fassnacht.

Alliqua completes transdermal discomfort patch initial in vitro study for treatment of PHN Alliqua.

Alliqua completes transdermal discomfort patch initial in vitro study for treatment of PHN Alliqua, Inc. , a sophisticated biomedical products company centered on the development and production of proprietary medication delivery and liver health technologies, announced today the effective completionContinue reading… Alliqua completes transdermal discomfort patch initial in vitro study for treatment of PHN Alliqua.

2009 Report Card.

‘It is necessary to note improvement – and I am happy to statement that we have observed minor upticks in the grades this season, specifically in the area of Medical Trials and Overall Federal government Commitment to enhancing the federalContinue reading… 2009 Report Card.

Chancery Division.

AGA refused permission to appeal UK Supreme Court for Figulla ASD and PFO occluder patent infringement In ’09 2009 the Patents Court of the High Court, Chancery Division, made the decision that Occlutech’s selection of Figulla ASD and PFO occludersContinue reading… Chancery Division.